Xu X - Search Results

1

Metabolomics study of treatment response to conbercept of patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.

Shen Y, Wang H, Xu X, Chen C, Zhu S, Cheng L, Fang J, Liu K, Xu X. Shen Y, et al. Among authors: xu x. Front Pharmacol. 2022 Sep 19;13:991879. doi: 10.3389/fphar.2022.991879. eCollection 2022. Front Pharmacol. 2022. PMID: 36199690 Free PMC article.

2

Reply.

Liu K, Xu X. Liu K, et al. Among authors: xu x. Am J Ophthalmol. 2019 Feb;198:263. doi: 10.1016/j.ajo.2018.09.029. Epub 2018 Nov 23. Am J Ophthalmol. 2019. PMID: 30477751 No abstract available.

3

Serum Metabolomics Reveals Personalized Metabolic Patterns for Macular Neovascular Disease Patient Stratification.

Liu K, Fang J, Jin J, Zhu S, Xu X, Xu Y, Ye B, Lin SH, Xu X. Liu K, et al. Among authors: xu x, xu y. J Proteome Res. 2020 Feb 7;19(2):699-707. doi: 10.1021/acs.jproteome.9b00574. Epub 2020 Jan 9. J Proteome Res. 2020. PMID: 31755721

4

KS23, a novel peptide derived from adiponectin, inhibits retinal inflammation and downregulates the proportions of Th1 and Th17 cells during experimental autoimmune uveitis.

Niu T, Cheng L, Wang H, Zhu S, Yang X, Liu K, Jin H, Xu X. Niu T, et al. Among authors: xu x. J Neuroinflammation. 2019 Dec 28;16(1):278. doi: 10.1186/s12974-019-1686-y. J Neuroinflammation. 2019. PMID: 31883532 Free PMC article.

5

Reply to Comment on: Conbercept for Treatment of Neovascular Age-Related Macular Degeneration: Results of the Randomized Phase 3 PHOENIX Study.

Liu K, Xu X, Kaiser PK, Rosenfeld PJ, Heier JS. Liu K, et al. Among authors: xu x. Am J Ophthalmol. 2020 Jul;215:154-155. doi: 10.1016/j.ajo.2019.12.007. Epub 2020 Mar 16. Am J Ophthalmol. 2020. PMID: 32192739 No abstract available.

6

Integrated bioinformatics analysis of aberrantly-methylated differentially-expressed genes and pathways in age-related macular degeneration.

Shen Y, Li M, Liu K, Xu X, Zhu S, Wang N, Guo W, Zhao Q, Lu P, Yu F, Xu X. Shen Y, et al. Among authors: xu x. BMC Ophthalmol. 2020 Mar 24;20(1):119. doi: 10.1186/s12886-020-01392-2. BMC Ophthalmol. 2020. PMID: 32209064 Free PMC article.

7

EFEMP1 Overexpression Contributes to Neovascularization in Age-Related Macular Degeneration.

Cheng L, Chen C, Guo W, Liu K, Zhao Q, Lu P, Yu F, Xu X. Cheng L, et al. Among authors: xu x. Front Pharmacol. 2021 Jan 15;11:547436. doi: 10.3389/fphar.2020.547436. eCollection 2020. Front Pharmacol. 2021. PMID: 33584252 Free PMC article.

8

Novel Peptide NT/K-CFY Derived from Kringle Structure of Neurotrypsin Inhibits Neovascularization.

Yao X, Chen C, Zhang J, Xu Y, Xiong S, Gu Q, Xu X, Suo Y. Yao X, et al. Among authors: xu x, xu y. Curr Eye Res. 2021 Oct;46(10):1551-1558. doi: 10.1080/02713683.2021.1907417. Epub 2021 Apr 19. Curr Eye Res. 2021. PMID: 33870816

9

Novel Peptide NT/K-CRS Derived from Kringle Structure of Neurotrypsin Inhibits Neovascularization In Vitro and In Vivo.

Yao X, Chen C, Zhang J, Xu Y, Xiong S, Gu Q, Xu X, Suo Y. Yao X, et al. Among authors: xu x, xu y. J Ocul Pharmacol Ther. 2021 Sep;37(7):412-420. doi: 10.1089/jop.2020.0120. Epub 2021 Jul 12. J Ocul Pharmacol Ther. 2021. PMID: 34252290

10

A novel 4.25 kb heterozygous deletion in PAX6 in a Chinese Han family with congenital aniridia combined with cataract and nystagmus.

Qian T, Chen C, Li C, Gong Q, Liu K, Wang G, Schrauwen I, Xu X. Qian T, et al. Among authors: xu x. BMC Ophthalmol. 2021 Oct 5;21(1):353. doi: 10.1186/s12886-021-02120-0. BMC Ophthalmol. 2021. PMID: 34610801 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57,437 results

Search Page

Filters